Scandinavian Journal of Gastroenterology · 1978 · 151 citations · 2 references
MedicinePharmacologyPharmacotherapyBowel ManagementClinical PharmacologyGastrointestinal PharmacotherapyAnti-inflammatory PharmacologyCrohn Disease PharmacotherapyGastrointestinal PharmacologyInflammatory Bowel DiseaseColonic InflammationDouble-blind TrialsInflammatory Bowel Disease PathophysiologyInflammatory Bowel Disease TherapyMetronidazole Therapy
Twenty-two patients with active Crohn's disease treated with salazosulfapyridin or prednisone, were in addition given metronidazole 1.000 mg daily or placebo for two months each in a double-blind cross-over study. No statistically significant effect was observed on the overall clinical condition in the 20 patients who completed the trial, although haemoglobin rose and ESR fell significantly in the metronidazole periods. In the 6 patients with colonic involvement only an improvement was registered both in symptoms and laboratory values.
2
METRONIDAZOLE FOR CROHN'S DISEASE
Bo Ursing, C. Kamme · The Lancet · 1975 · 208 citations
Metronidazole in the treatment of chronic proctitis: a controlled trial.
Paul S. Davies, JM Rhodes, R V Heatley et al. · Gut · 1977 · 44 citations · Full text